China Digest: C Ventures, BAI lead $20m round for RoboticPlus.AI; Innolake raises $46m
By Eudora Wang
April 7, 2021
Chinese architectural technology firm RoboticPlus.AI has secured $20 million in a Series B round, while newly-founded drugmaker Innolake Biopharm has closed 300 million yuan ($45.8 million) in a pre-Series A round.
Create an account to continue reading our free content.
Already have an account? Sign in here
Bring stories like this into your inbox every day.
Sign up for our newsletter – The Daily Brief
Related Stories
Chinese video streaming major Bilibili has proposed to invest $123m for a 4.72% stake in X.D. Network.
There were 122 PE-VC deals in the month that raised a combined $5.2b.